David Segal of the University of California, Davis in the U.S. will develop a high-throughput screen to search for artificial transcription factors (ATF) that are candidates to treat P. falciparum infections. ATFs could be a gene-regulating drug resource for the study and treatment of malaria.
Grant ID
OPP1061187
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False